Jon Fulgencio-Barbarin

9PUBLICATIONS
17CO-AUTHORS
AutoimmunityAllergyMedical parasitologyHaematological tumoursRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 30, 2026
Anifrolumab for lupus erythematosus in real-world practice: A Spanish national series.

|Feb 13, 2025
Skin lesions after hematopoietic stem cell transplantation: Graft-versus-host disease versus true dermatomyositis.

Alba Calleja Algarra, Borja González Rodriguez, Jon Fulgencio Barbarin

|Jan 22, 2023
Ulcero-necrotic monkeypox, a clue for an underlying immunosuppressive disease: Report of two cases.

B Gonzalez-Rodriguez, L Calderon-Lozano, A Wang

|Apr 15, 2022
Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas.

Daniel Falkenhain-López, Mario Puerta-Peña, Jon Fulgencio-Barbarin

|Feb 08, 2022
Two clinical subtypes with different management of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single centre experience.

Daniel Falkenhain-López, Alba Sánchez-Velázquez, Jon Fulgencio-Barbarin

|Sep 16, 2021
Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides.

D Falkenhain-López, J Fulgencio-Barbarin, M Puerta-Peña

Pageof 2